Infections in neutropenic cancer patients

Lancet

Volumn 359, Issue 9308, 2002, Pages 723-725

  Marchetti, Oscar ^a   Calandra, Thierry ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAM ANTIBIOTIC; CIPROFLOXACIN; CYTARABINE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC SENSITIVITY; BACTEREMIA; BACTERIAL INFECTION; BONE MARROW TRANSPLANTATION; CLINICAL TRIAL; DEVICE; DRUG MEGADOSE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; IMMUNE DEFICIENCY; INFECTION; INFECTION RATE; INFECTION RISK; MORBIDITY; MORTALITY; NEUTROPENIA; NOTE; PARASITOSIS; PRIORITY JOURNAL; RISK FACTOR; VIRUS INFECTION;

EID: 0037006641     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)07900-X     Document Type: Note

References (16)

1. Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer
2. Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients
3. Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients
4. A multicenter, double-blind, placebo-controlled trial comparing piperacillin-tazobactam with and without amikacin as empiric therapy for febrile neutropenia
5. Bacteremia due to viridans streptococci in neutropenic patients: A review
6. Efficacy of quinolone prophylaxis in neutropenic cancer patients: A metaanalysis
7. Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropenia
8. Reduction of fever and streptococcal bacteremia in granulocytopenic patients with cancer
9. Fluoroquinolone prophylaxis for the prevention of bacterial infections in patients with cancer-is it justified?
10. Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia
11. Risk assessment in cancer patients with fever and neutropenia: A prospective, two-center validation of a prediction rule
12. The Multinational Association for supporting care in cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients
13. Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy
14. A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy